News

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...
Experts warn that the surge in demand for weight loss injections like Ozempic and Wegovy is unsustainable, with most users ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...
Pharmacies have warned that the demand for weight loss medication risks going far beyond what is clinically deliverable 🚨 ...
New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...
A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to bolster market ...
Weight-loss jab Wegovy sees another prescription boost after ban on copycats - Novo CEO ousted in May, in place until ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Dozens of lawmakers are urging U.S. health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...